DR. RECKEWEG R13 Prohaemorrhin - Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X
Navigation: NDC > Supplier starting with: P > PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO| Field | Value |
|---|---|
| NDC Code: | 53346-1313 |
| Proprietary Name: | DR. RECKEWEG R13 Prohaemorrhin |
| Suffix: | Combination Product |
| Non-Proprietary Name: | Aesculus hippocastanum 2X, Collinsonia canadensis 4X, Graphites 8X, Hamamelis virginiana 3X, Kali carbonicum 6X, Lycopodium clavatum 5X, Nitricum acidum 6X, Nux vomica 4X, Paeonia officinalis 3X, Sulphur 5X |
| Dosage Form: | LIQUID |
| Method: | ORAL |
| Original Marketing Date: | 01-06-1986 |
| Category Name: | UNAPPROVED HOMEOPATHIC |
| Application Number: | |
| Labeler: | PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO |
| Substance Name: | COLLINSONIA CANADENSIS ROOT; GRAPHITE; HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK; HORSE CHESTNUT; LYCOPODIUM CLAVATUM SPORE; NITRIC ACID; PAEONIA OFFICINALIS ROOT; POTASSIUM CARBONATE; STRYCHNOS NUX-VOMICA SEED; SULFUR |
| Active Numerator Strength: | 4; 8; 3; 2; 5; 6; 3; 6; 4; 5 |
| Active Ingredient Unit: | [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL |
| Pharm Classes: | |
| DEA Schedule: |